Explanted Lung Tissues With Pulmonary Fibrosis
NCT00515567 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2026-01-13
Summary
The goal of this study is to use the tissues from the explanted lungs in order to better study the cause of pulmonary fibrosis at a cellular level.
Conditions
Sponsors & Collaborators
-
University of Chicago
lead OTHER
Principal Investigators
-
Nickolai Dulin, MD · University of Chicago
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Tissue Bank for Pulmonary Diseases
NCT00546962 ·Status: UNKNOWN
-
GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis
NCT07251725 ·Status: RECRUITING
-
Hyperpolarized Xenon MRI in Cystic Fibrosis Pulmonary Exacerbations
NCT02606487 ·Status: COMPLETED
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients
NCT00684346 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
NCT02109822 ·Status: COMPLETED
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
NCT03497117 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
NCT03138772 ·Status: COMPLETED
-
QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis
NCT00581997 ·Status: TERMINATED ·Phase: PHASE2
-
Biomarkers of Injury and Destruction in the Cystic Fibrosis Lung
NCT01805713 ·Status: COMPLETED
-
Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CF
NCT02464267 ·Status: COMPLETED
-
Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis Using Radiolabeled Fluorodeoxyglucose and PET Imaging
NCT00023465 ·Status: UNKNOWN
-
Exocrine Pancreatic Function Testing in Cystic Fibrosis
NCT01446861 ·Status: UNKNOWN
-
A Study to Investigate Cystic Fibrosis Pulmonary Exacerbations and the Lung Microbiome
NCT05088447 ·Status: TERMINATED
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
NCT01851642 ·Status: RECRUITING
-
Lung Transplantation for Pleuroparenchymal Fibroelastosis
NCT05044390 ·Status: UNKNOWN
-
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
NCT00750932 ·Status: COMPLETED
-
Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)
NCT06506773 ·Status: COMPLETED
-
Cystic Fibrosis and Frailtyh What's in Common?
NCT06020547 ·Status: COMPLETED
-
CAR-DC for End-Stage IPF
NCT07329959 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Platelets in Cystic Fibrosis Lung Inflammation
NCT05339724 ·Status: COMPLETED
-
MRI in Cystic Fibrosis and Primary Ciliary Dyskinesia
NCT03279965 ·Status: UNKNOWN